The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit

Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii

(2014) Irene Galani et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Activities of Vancomycin-Containing Regimens against Colistin-Resistant Acinetobacter baumannii Clinical Strains

(2013) Jessica A. O'Hara et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria

(2013) Nicola Petrosillo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

(2013) José Garnacho-Montero et al.   CHEMOTHERAPY

Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

(2013) Emanuele Durante-Mangoni et al.   CLINICAL INFECTIOUS DISEASES

Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative Bacilli

(2013) J. A. Hindler et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii

(2013) Ilkay Karaoglan et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Intravenous Colistin for Multidrug-Resistant Gram-Negative Infections in Critically Ill Pediatric Patients

(2013) Kapil Kapoor et al.   Pediatric Critical Care Medicine

Acinetobacter baumannii: evolution of a global pathogen

(2013) Luísa C.S. Antunes et al.   Pathogens and Disease

In VitroSynergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates

(2012) Céline Vidaillac et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroActivity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens

(2012) Michael Hornsey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii

(2012) Nabil Karah et al.   DRUG RESISTANCE UPDATES

Colistin: an update on the antibiotic of the 21st century

(2012) Silpak Biswas et al.   Expert Review of Anti-Infective Therapy

In vitroeffects of sulbactam combinations with different antibiotic groups against clinicalAcinetobacter baumanniiisolates

(2012) Aydin Deveci et al.   JOURNAL OF CHEMOTHERAPY

In VivoEfficacy of Glycopeptide-Colistin Combination Therapies in aGalleria mellonellaModel ofAcinetobacter baumanniiInfection

(2011) M. Hornsey et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients

(2011) Wang Liang et al.   BMC INFECTIOUS DISEASES

In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii

(2011) D. W. Wareham et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evidence of Diversity among Epidemiologically Related Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to International Clonal Lineage II

(2011) F. Minandri et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Antimicrobial Activity and Mutant Prevention Concentration of Colistin against Acinetobacter baumannii

(2010) Y. Cai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii

(2010) N. C. Gordon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy

(2010) Silvia D'Arezzo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists

(2009) Michael J. Rybak et al.   CLINICAL INFECTIOUS DISEASES

Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine

(2009) Abdel Moati Kh. Al Jarousha et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Intravenous Colistimethate (Colistin) Use in Critically Ill Children Without Cystic Fibrosis

(2009) Matthew E. Falagas et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options

(2008) Lisa L. Maragakis et al.   CLINICAL INFECTIOUS DISEASES